How evolution evolved: the risks and rewards of gene-editing technology - India Block speaks to paediatrician and TV writer ...

Nov. 6, 2024 — The CRISPR tool is capable of repairing the genetic defect responsible for the immune disease chronic granulomatous disease. However, researchers have now shown that there is a ...

Spanning three days from November 28 to 30, the conference brought together luminaries from diverse disciplines, including ...

Crispr Therapeutics is a clinical-stage gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly ...

Next year is the 100th anniversary of the Scopes Monkey Trial. That case was the most famous challenge to the teaching of ...

Researchers in Lithuania present the molecular structure of a new, more-versatile CRISPR system for gene editing. Scientists have unveiled a new version of the famous gene-editing tool CRISPR ...

Synthetic biology techniques have emerged as transformative tools in the tug-of-war between humans and drug-resistant ...

Cells can now be genetically programmed to record their histories within their genomes, a development that could ...

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

On Nov. 21, shares of CRISPR Therapeutics (NASDAQ: CRSP) were down 47% from a peak they reached in March. After all, it's been less than a year since regulators in the U.S. and E.U. approved its ...